Show simple item record

dc.contributor.authorReinhardt, HC
dc.contributor.authorHasskamp, P
dc.contributor.authorSchmedding, I
dc.contributor.authorMorandell, S
dc.contributor.authorvan Vugt, MATM
dc.contributor.authorWang, X
dc.contributor.authorLinding, R
dc.contributor.authorOng, S-E
dc.contributor.authorWeaver, D
dc.contributor.authorCarr, SA
dc.contributor.authorYaffe, MB
dc.date.accessioned2018-08-17T09:41:52Z
dc.date.issued2010-10-08
dc.identifier1
dc.identifier.citationMOLECULAR CELL, 2010, 40 pp. 34 - 49
dc.identifier.issn1097-2765
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2350
dc.identifier.doi10.1016/j.molcel.2010.09.018
dc.description.abstractFollowing genotoxic stress, cells activate a complex kinase-based signaling network to arrest the cell cycle and initiate DNA repair. p53-defective tumor cells rewire their checkpoint response and become dependent on the p38/MK2 pathway for survival after DNA damage, despite a functional ATR-Chk1 pathway. We used functional genetics to dissect the contributions of Chk1 and MK2 to checkpoint control. We show that nuclear Chk1 activity is essential to establish a G(2)/M checkpoint, while cytoplasmic MK2 activity is critical for prolonged checkpoint maintenance through a process of post-transcriptional mRNA stabilization. Following DNA damage, the p38/MK2 complex relocalizes from nucleus to cytoplasm where MK2 phosphorylates hnRNPA0, to stabilize Gadd45 alpha mRNA, while p38 phosphorylates and releases the translational inhibitor TIAR. In addition, MK2 phosphorylates PARN, blocking Gadd45 alpha mRNA degradation. Gadd45a functions within a positive feedback loop, sustaining the MK2-dependent cytoplasmic sequestration of Cdc25B/C to block mitotic entry in the presence of unrepaired DNA damage. Our findings demonstrate a critical role for the MK2 pathway in the posttranscriptional regulation of gene expression as part of the DNA damage response in cancer cells.
dc.format.extent34 - 49
dc.languageeng
dc.language.isoeng
dc.publisherCELL PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleDNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/j.molcel.2010.09.018
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2010-10-08
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfMOLECULAR CELL
pubs.notesaffiliation: Yaffe, MB (Reprint Author), MIT, David H Koch Inst Integrat Canc Res, Dept Biol, Boston, MA 02132 USA. Reinhardt, H. Christian; Hasskamp, Pia; Schmedding, Ingolf; Morandell, Sandra; Yaffe, Michael B., MIT, David H Koch Inst Integrat Canc Res, Dept Biol, Boston, MA 02132 USA. Ong, Shao-En; Carr, Steven A.; Yaffe, Michael B., MIT & Harvard, Broad Inst, Cambridge, MA 02132 USA. Yaffe, Michael B., MIT, Dept Biol Engn, Ctr Cell Decis Proc, Boston, MA 02132 USA. Linding, Rune, Inst Canc Res, London SW3 6JB, England. van Vugt, Marcel A. T. M., Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9700 RB Groningen, Netherlands. Reinhardt, H. Christian, Univ Hosp Cologne, Dept Internal Med, Div 1, D-50937 Cologne, Germany. Reinhardt, H. Christian, Max Planck Inst, Oncogene Signaling Grp, D-50931 Cologne, Germany. Reinhardt, H. Christian, Collaborat Res Ctr 832, D-50937 Cologne, Germany. Wang, XiaoZhe; Weaver, David, On Q Ity, Waltham, MA 02451 USA. keywords-plus: ONCOGENE-INDUCED SENESCENCE; AU-RICH ELEMENTS; MAPKAP KINASE-2; NUCLEAR EXPORT; CANCER-CELLS; MEDIATE ACTIVATION; PHOSPHORYLATION; STRESS; GADD45; CHK1 research-areas: Biochemistry & Molecular Biology; Cell Biology web-of-science-categories: Biochemistry & Molecular Biology; Cell Biology author-email: [email protected] funding-acknowledgement: NIH [ES015339, GM68762, CA112967]; Deutsche Forschungsgemeinschaft (DFG) [RE2246/1-1, RE2246/2-1, SFB 832]; David H. Koch Fund funding-text: We gratefully acknowledge M. Gorospe (National Institutes of Health [NIH]), P. Cohen (Dundee), A. Virtanen (Uppsala), T. Benzing (Cologne), and M. Hemann (Massachusetts Institute of Technology) for kindly providing reagents. Mary Stewart, Drew Lowery, Isaac A. Manke, and Duaa H. Mohammad provided helpful advice and technical support. We are grateful to the imaging (E. Vasile) and flow cytometry (G. Paradis) core facilities of the Koch Institute for Integrative Cancer Research. This work was funded by NIH grants ES015339, GM68762, and CA112967 to M.B.Y. Funding for H.C.R. was provided by the Deutsche Forschungsgemeinschaft (DFG) (RE2246/1-1, RE2246/2-1, and the SFB 832) and the David H. Koch Fund (to H.C.R. and M.B.Y.). number-of-cited-references: 53 times-cited: 115 usage-count-last-180-days: 0 usage-count-since-2013: 10 journal-iso: Mol. Cell doc-delivery-number: 673XP unique-id: ISI:000283697800006 oa: gold_or_bronze da: 2018-08-17
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR
pubs.volume40
pubs.embargo.termsNot known
dc.contributor.icrauthorLinding, Rune


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0